Joel Moss, MD, PhD, Wins Prestigious NIH Orloff Award
The LAM Foundation congratulates Joel Moss, MD, PhD, for winning the 2016 National Institutes of Health Orloff Award. Dr. Moss and his team won this award for demonstrating the effects of therapy, hormonal status and cell signaling pathways on the detection and characterization of circulating tumor cells in patients with lymphangioleiomyomatosis (LAM) and tuberous sclerosis complex (TSC) and in models of tumorigenesis.
NHLBI Director, Gary H. Gibbons, MD, and NHLBI IC Director, Robert Balaban, PhD, selected Dr. Moss and his team for this award because if for their achievements in basic science, clinical applications and innovative methodology and technology.
You can view a brief video presentation of Dr. Moss and his work by clicking here.